Head of the European Cannabis Sector Group at Dentons
"I'm happy to give cannabis founders the knowledge they need to evaluate chances, opportunities to deliver cannabis patients their medication they need."
We are looking forward seeing you at a future event (starting at 5 pm).
On the occasion of the recent first discount contracts for the prescription of medical cannabis: What is behind the system of discount agreements between German statutory health insurance funds and pharmaceutical manufacturers? And what consequences does it have?
Under what conditions does a German health insurance reimburse the costs of medicinal products containing cannabis? And what is required of patients and prescribing doctors in the process?
Today´s topic is “Legalization in Europe – Possible Candidates for Legalization" where Peter is going through the major countries in the EU.
The German government has targeted the legalization of recreational cannabis. Internationally, the trend is evident. But how can we overcome the many obstacles of international law?
Peter Homberg is giving us an overview about the products which git a recall in Germany and why. He is also explaining which institute is in charge of the different kind of products.
Peter Homberg is giving us the latest overview of how and when the parties will define the future legalization of cannabis in Germany.
Peter Homberg will introduce you to the parties we have in Germany and might going coalate to have an opinion on the legalization of cannabis in Germany.
Peter Homberg talks about the different kind of dosage forms we have currently in the market to the final categorization of each product.
Peter Homberg talks about the right insurance coverage for importing and selling medical cannabis in Germany.
The recent news were from Lesoto which means new developments in Europe.
We are talking about the current state of regulation of the sale of CBD flowers here in Germany regarding the last court decision at the end of March.
What are suitable corporate forms as start-up vehicles in the field of importing and distributing medicinal cannabis?
What are the regulatory requirements for the importation and distribution of medical cannabis?
What are the restrictions on the trade of CBD products as cosmetics and novel food and what effects has the ECJ decision on the classification of CBD as a narcotic?
Im adding you to the mailling list and notify you.